Diabetes & Kidney Health
UT Health San Antonio physician-scientists are pioneering world-class research in diabetes and kidney diseases and other metabolic disorders and translating discoveries as they educate our next generation of physician-scientists.
Carolina Solis-Herrera, M.D.
2018 Voelcker Fund Young Investigator Award
Under the leadership of Dr. Kumar Sharma, holder of the L. David Hillis, M.D. Endowed Chair, the Division of Nephology has been awarded several large NIH grants, including an NIH funded Kidney Precision Medicine Tissue Interrogation grant.
UT Health San Antonio is the premier site for localizing molecules in human kidney biopsies, redefining causes of common, and rare, kidney disease.
Clinical trial participation is an invaluable way to contribute to the pursuit of new treatments for diabetes and kidney diseases. Take action today...volunteer and play a role in finding a cure.
Find
Ralph DeFronzo, M.D., holder of the Joe R. and Teresa Lozano Long Distinguished Chair in Diabetes and 2017 Harold Hamm International Prize Laureate, is ranked among the Top 6 experts of type 2 diabetes mellitus worldwide according to Expertscape.
Additional Highlights
-
NASA twins study includes San Antonio multiomics center
Kumar Sharma, M.D., and Manjula Darshi, Ph.D., from UT Health San Antonio's Center for Renal Precision Medicine, together with Brinda Rana, Ph.D., from the University of California, San Diego, led one of the teams of investigators involved in a unique study on spaceflight. The study is examining the effects of a year's spaceflight on NASA astronaut Scott Kelly in comparison to his identical twin and fellow astronaut, Mark Kelly, who reamined on Earth.
Learn more about the division of Nephrology -
Youth-onset Type 2 diabetes is derailing the lives of young adults
Jane Lynch, M.D., a pediatric endocrinologist at UT Health San Antonio, is truly on the front lines of San Antonio's alarming increase of Type 2 diabetes in children.
Read the full article in Newsroom -
Collaboration between San Antonio's four leading research institutions will lead to personalized therapies
A special story in the San Antonio Business Journal highlights the recently announced San Antonio Partnership for Precision Therapeutics and the work of Dr. Kumar Sharma.
Read the article at San Antonio Business Journal -
Dr. Sara Espinoza conducting NIH-funded study to test metformin
Dr. Espinoza and her team are conducting a major NIH-funded study to test metformin as a novel intervention for the prevention of fraility, a clinical geriatric syndrome of progressive physical and physiologic decline that is known to increase risk for multiple adverse outcomes with aging.
Register on Research Match